Wegovy is a weight loss medication containing semaglutide, which mimics the GLP-1 hormone to help regulate appetite and food intake. It has shown superior efficacy in clinical trials compared to other weight loss medications, resulting in an average weight loss of around 15% over 68 weeks. Wegovy not only helps with weight loss but also reduces the risk of cardiovascular events in individuals with obesity or overweight. The medication is administered through weekly injections and is effective when combined with lifestyle changes. Patients should be aware of potential side effects, cost considerations, and insurance coverage when considering Wegovy as a weight loss option.
Source link
What Makes Wegovy Semaglutide Stand Out Among Weight Loss Medications?
